WAY-296817
CAS No. 349438-74-0
WAY-296817( —— )
Catalog No. M28483 CAS No. 349438-74-0
WAY-296817 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention of diseases associated with circadiantiazol rhythm, inflammation diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 71 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 98 | In Stock |
|
| 25MG | 179 | In Stock |
|
| 50MG | 252 | In Stock |
|
| 100MG | 346 | In Stock |
|
| 200MG | 474 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWAY-296817
-
NoteResearch use only, not for human use.
-
Brief DescriptionWAY-296817 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention of diseases associated with circadiantiazol rhythm, inflammation diseases.
-
DescriptionWAY-296817 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention of diseases associated with circadiantiazol rhythm, inflammation diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetCasein Kinase
-
RecptorCB2R
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number349438-74-0
-
Formula Weight328.39
-
Molecular FormulaC17H16N2O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (380.64 mM)
-
SMILESCOc1ccc2nc(NC(=O)Cc3ccccc3OC)sc2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CK2 inhibitor 2
CK2 inhibitor 2 is a potent and selective CK2 inhibitor(IC50 = 0.66 nM) with favorable antiproliferative and antitumor activity.
-
CAM4066
CAM4066 (CAM-4066) is a potent and selective CK2α inhibitor with Kd of 0.32 uM and IC50 of 0.37 uM.
-
Epiblastin A
Epiblastin A is an inhibitor of Casein Kinase 1 (CK1).?Epiblastin A engages CK1 isoenzymes in cell lysate and induces efficient conversion of epiblast stem cells (EpiSCs) into embryonic stem cells (cESCs).
Cart
sales@molnova.com